Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Introduction: the immune response against dying cells
Laurence Zitvogel, Guido Kroemer
Current Opinion in Immunology (2008) Vol. 20, Iss. 5, pp. 501-503
Closed Access | Times Cited: 12

Showing 12 citing articles:

Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation
Miriam B. Torchinsky, Johan Garaude, Andrea P. Martin, et al.
Nature (2009) Vol. 458, Iss. 7234, pp. 78-82
Closed Access | Times Cited: 353
Dendritic cells and their role in atherogenesis
Yuri V. Bobryshev
Laboratory Investigation (2010) Vol. 90, Iss. 7, pp. 970-984
Open Access | Times Cited: 97
Viral subversion of immunogenic cell death
Oliver Kepp, Laura Senovilla, Lorenzo Galluzzi, et al.
Cell Cycle (2009) Vol. 8, Iss. 6, pp. 860-869
Open Access | Times Cited: 63
Various ways to improve whole cancer cell vaccines
Laetitia Cicchelero, H. de Rooster, Niek N. Sanders
Expert Review of Vaccines (2014) Vol. 13, Iss. 6, pp. 721-735
Closed Access | Times Cited: 48
Death-Defining Immune Responses After Apoptosis
Laura Campisi, Ryan J. Cummings, J. Magarian Blander
American Journal of Transplantation (2014) Vol. 14, Iss. 7, pp. 1488-1498
Open Access | Times Cited: 44
Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored
Roger Mouawad, Jean‐Philippe Spano, David Khayat
Journal of Clinical Oncology (2011) Vol. 29, Iss. 15, pp. 1935-1936
Closed Access | Times Cited: 18
The danger model in deciphering autoimmunity
Anders Tveita
Lara D. Veeken (2010) Vol. 49, Iss. 4, pp. 632-639
Open Access | Times Cited: 15
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity
Paulina M. Wojnarowicz, Karen Gambaro, Manon de Ladurantaye, et al.
Oncogenesis (2012) Vol. 1, Iss. 9, pp. e27-e27
Open Access | Times Cited: 13
Nominal and neighboring-optimal control approaches to the adoptive immunotherapy for cancer
Amine Hamdache, Smahane Saadi, Ilias Elmouki
International Journal of Dynamics and Control (2015) Vol. 4, Iss. 3, pp. 346-361
Closed Access | Times Cited: 10
Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?
Laetitia Cicchelero, Sofie Denies, Bert Devriendt, et al.
OncoImmunology (2015) Vol. 4, Iss. 12, pp. e1048413-e1048413
Open Access | Times Cited: 6
Immune cell infiltrate in different grades of astrocytomas
Maha M. Amin, Abdelaty Shawky, Ahmed Zaher, et al.
Egyptian Journal of Pathology (2012) Vol. 32, Iss. 1, pp. 175-180
Open Access | Times Cited: 3
Apoptosis
María Luisa Campo
Springer eBooks (2009), pp. 17-55
Closed Access | Times Cited: 2
Page 1

Scroll to top